← Leaderboards
Vaibhav Sahai
University Of Michigan At Ann Arbor
$809,149
Attributed
$2,427,447
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $489.4K · FY2019–23$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,427,447 · 1
By mechanism
R01$2,427,447 · 1
Top collaborators
- Mats Ljungman5 shared
- Nouri Neamati5 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Marina Pasca Di Magliano$14,782,555
- Mats Ljungman$9,091,730
- Timothy Louis Frankel$4,183,486
- Judith S Leopold$7,991,997
- Alice Telesnitsky$37,945,631
Others in their field
Other Emerging Leaders on “Innovation”
- Klaus Romero · Critical Path Institute$86,053,372
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Ted Ross · University Of Georgia$70,992,558
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$69,953,681
- Tony Moody · Duke University$65,625,959
- Matthew Johnson · Duke University$60,590,296
Research focus
InnovationAnti-CancerGrantBioluminescenceBiotinBodipyBiologyAuxinsCell DeathCell ProliferationCellsCell SurvivalCellular TargetingChemosensitizationChemotherapeutic AgentCancer CellCancer Cell LineEpithelial CellsEventExosomeGemcitabineGenerationsGenetic TranscriptionIn Vitro
Grant awards (5)
Targeting the RNA Exosome for Cancer Therapeutics$479,616
R01 · FY2023 · CA
Targeting the RNA Exosome for Cancer Therapeutics$479,616
R01 · FY2022 · CA
Targeting the RNA Exosome for Cancer Therapeutics$489,405
R01 · FY2021 · CA
Targeting the RNA Exosome for Cancer Therapeutics$489,405
R01 · FY2020 · CA
Targeting the RNA Exosome for Cancer Therapeutics$489,405
R01 · FY2019 · CA